Although previous studies reveal that KIF18A is a marker for prognosis and immunity of various cancers [17, 18], it is uncertain if KIF18A inhibition may affect antitumor immunity of CIN+ colorectal tumors. The gene discussed is KIF18A; the disease is cancer.